A transcutaneous electrical nerve stimulation device for the relief of neuropathic pain in NMOSD: A randomized, double-blind, sham-controlled trial
In conclusion, there was no demonstrated benefit of TENS over sham TENS treatment, however, both arms demonstrated significant decreases in reported pain between baseline and 4 weeks. This trial is registered with ClinicalTrials.gov, NCT04614454.
Authors
- Gabriela Romanow
- Anastasia Vishnevetsky (ORCID: https://orcid.org/0000-0002-0269-7441)
- Michael Levy (ORCID: https://orcid.org/0000-0002-7969-8346)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1177/20552173241301018
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00